1. Home
  2. CRL vs WSE Comparison

CRL vs WSE Comparison

Compare CRL & WSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$293.36

Market Cap

13.1B

Sector

Health Care

ML Signal

HOLD

Logo Wise Group plc Class A Ordinary Shares

WSE

Wise Group plc Class A Ordinary Shares

N/A

Current Price

$11.60

Market Cap

12.6B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CRL
WSE
Founded
1947
N/A
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Diversified Commercial Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.1B
12.6B
IPO Year
1999
2025

Fundamental Metrics

Financial Performance
Metric
CRL
WSE
Price
$293.36
$11.60
Analyst Decision
Buy
Analyst Count
12
0
Target Price
★ $198.27
N/A
AVG Volume (30 Days)
827.6K
★ 1.4M
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,857,601,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.04
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 10.48
N/A
52 Week Low
$145.47
$10.78
52 Week High
$303.31
$13.66

Technical Indicators

Market Signals
Indicator
CRL
WSE
Relative Strength Index (RSI) 61.22 40.45
Support Level $267.27 $11.22
Resistance Level $303.31 $13.23
Average True Range (ATR) 9.37 0.27
MACD 0.17 -0.08
Stochastic Oscillator 86.35 28.06

Price Performance

Historical Comparison
CRL
WSE

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.

About WSE Wise Group plc Class A Ordinary Shares

Wise is a currency conversion platform that matches, where possible, offsetting currency transactions across borders to reduce costs. The group focuses primarily on private clients and small and midsize enterprises, but it is building out its platform business aimed at providing its services as a backend solution to banks. By operating local accounts in each jurisdiction Wise sends money to or receives money from, this fintech offers faster and cheaper currency transfer services than incumbents (banks). Wise has started to broaden its product offering, issuing its clients debit cards and allowing customers to invest funds in various asset management products.

Share on Social Networks: